Summary
In the Western industrialized nations, stroke is the third leading cause of death and the number one cause of acquired disability. To optimize the therapeutic options available to these patients, early signs of stroke need to be recognized and treatment has to be initiated within 3 hours from symptom onset. A „chain of stroke-management“ consisting of an early diagnosis and rapid prehospital treatment, efficient diagnostic procedures, and subsequent initiation of acute therapy is required. This article provides an overview of this approach. Focus is directed at the prehospital phase because, in contrast to trauma or myocardial infarction, the signs of stroke are often not recognized as readily by relatives and bystanders or even by medical staff and emergency medical services (EMS), which causes treatment delays. Therefore, by informing the public better and educating emergency personnel concerning stroke, the number of stroke patients treated as an emergency could increase. Prehospital treatment can be targeted towards adequate cerebral oxygenation and individual management of hypertension, treatment of cardiac arrhythmia, and preventing hyperglycemia and hyperthermia. Optimizing the initiation of in-hospital treatment requires early notification of the emergency room personnel in the selected hospital (stroke unit/ stroke team, 24-hour CCT).
Zusammenfassung
In westlichen Industrienationen ist der Schlaganfall die dritthäufigste Todesursache und die häufigste Ursache für erworbene Behinderungen überhaupt. Optimale Behandlungsbedingungen bestehen nur dann, wenn die Frühsymptome des Schlaganfalls rechtzeitig erkannt werden und die Behandlung innerhalb von 3 h nach Einsetzen der Erstsymptome eingeleitet wird. Eine „Rettungskette des Schlaganfalls” muss deshalb Konzepte zur Früherkennung, eine rasche prähospitale Versorgung gefolgt von effizienter Diagnostik und eine unmittelbar einsetzende Akuttherapie sinnvoll integrieren. Der vorliegende Beitrag hat zum Ziel, diesen Ansatz unter besonderer Berürcksichtigung der prähospitalen Phase darzustellen. Diese Akzentuierung erscheint notwendig, da dem Schlaganfall im Vergleich zum Trauma oder Herzinfarkt weitaus weniger Priorität beigenmesse wird. Laien, aber auch rettungsdienstliches und medizinisches Personal erschweren durch diese Auffassung die notfallmäßige Behandlung von Schlaganfallpatienten. Intensivierte Aufklärungs- bzw. Ausbildungsmaßnahmen, die sowohl die Öffentlichkeit als auch notfallmedizinisches Personal berücksichtigen, können eine Verbesserung dieser Situation erreichen. Die Zielgrößen der prähospitalen Behandlung sind eine adäquate zebrale Oxygenierung , ein an den einzelnen Patienten angepasstes Blutdruckniveau, die Behandlung von Herzrhythmusstörungen und das Vermeiden von Hyperglykämie, Hypoglyämie und Hyperthermie. Ein optimaler ßbergang von der prähospitalen in die hospitale Phase der Versorgung ergordert die frühzeitige Anmeldung des Schlaganfallpatienten in der geeigneten Klinik (Stroke-Unit/Stroke-Team, 24-Studen CCT).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams HP, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M (1994) Guidelines for the management of patients with acute ischemic stroke. Stroke 25:1901–1914
Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 27:1711–1718
Alberts MJ, Perry A, Dawson DV, Bertels C (1992) Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 23:352–356
American Heart Association (AHA) and International Liasion Committee on Resuscitation (ILCOR) (2000) Guidelines 2000 for cardiopulmonary Resuscitation and emergency cardiovascular care. An international consensus on science. Part 1: Introduction to the international guidelines 2000 for CPR and ECC. Circulation 102(Suppl):Il-I11
Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12:723–725
Britton M, Carlsson A, de Faire U (1986) Blood pressure course in patients with acute stroke and matched controls. Stroke 17:861–864
Bronstein KS, Chadwick LR (1994) Ticlopidine hydrochloride: its current use in cerebrovascular disease. Rehabil Nursing 19:17–20
Brott T (1997) Reopening occluded cerebral arteries. In: Bogousslaysky J (ed) Acute stroke treatment. Martin Dunitz, London, pp 109–148
Brott T, MacCarthy EP (1989) Antihypertensive therapy in stroke. In: Fischer M (ed) Medical therapy of acute stroke, Vol 2, Marcel Dekker, New York Basel, pp 117–141
Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5
Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD (1999) Acute blood glucose level and outcome from ischemic stroke. Neurology 52:280–284
Bundesarztekammer (Hrsg) (1995) Kursbuch Rettungsdienst. Curriculum zum Fachkundenachweis Rettungsdienst, Köln
Chalmers J (1998) Volhard lecture. Brain, blood pressure and stroke. J Hypertens 16:1849–1858
Davalos A, Castillo J, Pumar JM, Noya M (1997) Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Journal of Cerebrovascular Diseases 7:64–69
del Zoppo GJ, Zeumer H, Harker LA (1986) Thrombolytic therapy in stroke: possibilities and hazards. Stroke 17:595–607
Demchuk AM, Morgenstern LB, Krieger D, Chi TL, Hu W, Wein TH, Hardy RJ, Grotta J, Buchan A (1999) Serum Glucose level and Diabetes predict Tissue Plasminogen Activator Releted intracerebral hemorrhage in acute ischemic stroke. Stroke 30:34–39
Diener H, Hacke W, Hennerici M (1996) Lubeluzole in acute ischemic stroke: a double-blind placebo controlled phase II trial. Stroke 27:76–81
Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, Koudstaal P, Wessel T (2000) Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 31:2543–2551
Dyker AG, Lees KR (1998) Duration of neuroprotective treatment for ischemic stroke. Stroke 29:535–542
Ellinger K, Koch C, Daffertshofer M, Behrens S, Luiz Th (1999) Das Mannheimer Schlaganfallprojekt - Eine Initiative zur Optimierung der Versorgungsstrategie. Notfall & Rettungsmedizin 2:428–433
Engelhard K, Werner C, Lu H, Mollenberg O, Zieglgansberger W, Kochs E (2000) Der neuroprotektive Einfluss des Glutamat-Antagonisten Acamprosat nach experimenteller zerebraler Ischamie. Ein Vergleich mit dem Lipidperoxidase-Inhibitor U-101033e. Anaesthesist 49:816–821
Ginsberg MD, Busto R (1998) Combating hyperthermia in acute stroke. Stroke 29:529–534
Green AR (1998) Clomethiazole (Zendra) in acute ischemic stroke: Basic pharmacology and biochemistry and clinical efficacy. Pharmacol Ther 80:123–147
Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss W-D (1998) Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29:1544–1549
Grotta J, Pasteur W, Khwaja G, Hamel T, Fisher M, Ramirez A (1995) Elective intubation for neurologic deterioration after stroke. Neurology 45: 640–644
Hall ED (1996) Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur J Anaesth 13:279–289
Harper G, Castleden CM, Potter JF (1994) Factors affecting changes in blood pressure after acute stroke. Stroke 25:1726–1729
Heiss WD, Thiel A, Grond M, Graf R (1999) Which targets are relevant for therapy of acute ischemic stroke? Stroke 30:1486–1489
Hennes HJ, Heid F, Steiner Th (1999) Praklinisches Management des Patienten mit Schlaganfall. Anaesthesist 48:858–870
Hossmann KA (1994) Viability threshold and the penumbra of focal ischemia. Ann Neurol 36:557–565
Jantzen J-P, Fischer F (1999) Verbesserung der zerebralen Perfusion bei intrakranieller Blutung. In: Hennes HJ (Hrsg) Andsthesiologische Aspekte der gestorten zerebralen Perfusion. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S 93–95
Kasner SE, Grotta J (1997) Emergency identification and treatment of acute ischemic stroke. Ann Emerg Med 30:642–653
Kassell NF, Haley EC, Apperson-Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221–228
Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, Katalinic A, Lang E, Gassmann K-G, von Stockert T (1998) A prospective community-based study of stroke in Germany -The Erlangen stroke project (ESPro). Stroke 29:2501–2506
Kothari R, Barsan W, Brott T, Broderick J, Ashbrock S (1995) Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke 26:937–941
Kothari R, Hall K, Brott T, Broderick J (1997) Early stroke recognitation: Developing an out-of-hospital NIH stroke scale. Acad Emerg Med 4:986–990
Kothari RU, Brott T, Broderick JP, Hamilton CA (1995) Emergency physicians. Accuracy in the diagnosis of stroke. Stroke 26:2238–2241
Kothari RU, Pancioli A, Liu T, Brott T, Broderick J (1999) Cincinnati pre-hospital stroke scale: Reproducibility and validity. Ann Emerg Med 33:373–378
Kurtenbach H, Gorgass B, Raps W (Hrsg) (1990) Rettungsassistentengesetz. Kohlhammer, Kohl, S 12
Lechleuthner A, Grond M (1998) Pre-hospital triage of acute stroke for lysis - implementation and results of 60 cases after 1 year. Eur J Emerg Med 5:114–114
Levine SR, Gorman M (1999) „Telestroke“ - The application of telemedicine for stroke. Stroke 30:464–469
Libman RB, Wirkowski E, Alvir J, Rao TH (1995) Conditions That Mimic Stroke in the Emergency Department. Arch Neurol 52:1119–1122
Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, Barron BJ (1993) Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 50:855–862
Lott C, Hennes HJ, Dick W (1999) Stroke - a medical emergency. J Accid Emerg Med 16:2–12
MacDonald JW, Silverstein FS, Johnston MV (1990) Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 109:234–238
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774
MacPherson P, Graham DI (1978) Correlation between angiographic findings and the ischaemia of head injury. Journal of Neurology, Neurosurgery, and Psychiatry 41:122–127
Marrannes R, De-Prins E (2000) Site of action of lubeluzole on voltage-sensitive Ca(2+) channels in isolated dorsal root ganglion cells of the rat: influence of the pH. J Pharmacol Exp Ther 295:531–545
Moecke H, Dirks B, Friedrich H-J, Hennes H-J, Lackner C-K, Messelken M, Neumann C, Pajonk F-G, Reng M, Schachinger U, Violka T (2000) DIVINotarzteinsatzprotokoll, Version 4.0. Anaesthesist 49:211–349
O’Connel JE, Gray CS (1994) Treating hypertension in acute stroke. BMJ 308:1523–1524
Oppenheimer SM, Hachinski VC (1992) The cardiac consequences of stroke. Neurol Clin 10:167–176
Pepe PE, Zachariah BS, Sayre MR, Floccare D (1998) Ensuring the chain of recovery for stroke in your community. Acad Emerg Med 5:352–358
Robertson C, Steen P, Adgey J, Bossaert L, Carli P, Chamberlain D, Dick W, Ekstrom L, Hapnes SA, Holmberg S, Juchems R, Kette F, Koster R, de Latorre FJ, Lindner K, Perales N (1998) The 1998 European Resuscitation Council guidelines for adult advanced life support. Resuscitation 37: 81–90
Sandercock PAG, van den Belt AGM, Lindley RI, Slattery J (1993) Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurosurg Psychiatry 56:17–25
Schrader J, Rothemeyer M, Ltiders S, Kollmann K (1998) Hypertension and stroke - rationale behind the ACCESS trial. Basic Res Cardiol 93:69–78
Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W (1998) Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29:2461–2466
Sieber FE, Traystman RJ (1992) Glucose and the brain. Crit Care Med 20:104–114
Solis O, Robertson G, Taveras J, Mohr J, Pessin M (1979) Cerebral angiography in acute cerebral infarction. Rev Interam Radiol 2:19–25
Spitzer K, Becker V, Kunze K (1989) The Hamburg stroke data bank: goals, design and preliminary results. J Neurol 236:139–144
Steiner T, Mendoza G, De Georgia M, Schellinger P, Holle R, Hacke W (1997) Prognosis of stroke patients requiring mechanical ventilation in a neurologic care unit. Stroke 28:711–715
Steiner T, Hennes H-J, Kretz R, Hacke W (2000) Akute klinische Schlaganfallbehandlung. Anaesthesist 49:2–8
Steiner T, Hennes H-J, Ringleb P, Bertram M, Hacke W (1999) Zeitbasiertes Management des akuten Schlaganfalls. Notfall & Rettungsmedizin 2:400–407
Steiner T, Schellinger P (1999) Auswahlkriterien fur die Krankenhausaufnahme bei der Verdachtsdiagnose Schlaganfall. Notfall & Rettungsmedizin 2:434–435
The American-Canadian Co-Operative Study Group (1985) Persantine aspirin trial in cerebral ischaemia. Part II: Endpoint results. Stroke 16:406–415
The European Ad Hoc Consensus Group (1998) Neuroprotection as initial therapy in acute stroke. Third report of an Ad Hoc Consensus Group Meeting. Cerebrovasc Dis 8:59–72
The National Institute of Neurological Disorders and Stroke (NINDS) rtPA Stroke Study Group (1997) A systems approach to immediate evaluation and management of hyperacute stroke. Stroke 28:1530–1540
The RANTTAS Investigators (1996) Randomized trial of tirilazad in acute stroke (RANTTAS) by the RANTTAS investigators, the neuroclinical centre, University of Charlottsville, VA, and the North American RANTTAS participants. Stroke 27:164–164
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A, Schroll M (1995) Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke 26:361–367
Wahlgren NG, Diez-Tejedor E, Teitelbaum J, Arboix A, Leys D, Ashwood T (2000) Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clometiazole versus placebo in acute stroke patients. Stroke 31:82–85
Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T (1994) Intravenous Nimodipine West European Stroke Trial of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 4:197–203
Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PMM, Ashwood T, Claesson L (1999) Clomethiazole Acute Stroke Study (CLASS). Stroke 30:21–28
Weir CJ, Murray GD, Dyker AG, Lees KR (1997) Is hyperglycaemia an indipendent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 314:1303–1306
Zivin JA (1998) Factors determining the therapeutic window for stroke. J Neurol 50:599–603
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Heid, F., Hennes, HJ., Steiner, T. (2003). Schlaganfallversorgung in der Prähospitalphase. In: Die Notfalltherapie und Intensivtherapie bei Schlaganfall. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57384-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-57384-2_2
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1384-6
Online ISBN: 978-3-642-57384-2
eBook Packages: Springer Book Archive